|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.38 SEK | +0.31% |
|
+2.90% | -12.36% |
| Mar. 25 | Senzagen Receives Follow-Up Order Worth SEK 0.8 Million from the Global Chemicals Leader | CI |
| Mar. 22 | SenzaGen AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
SenzaGen AB reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported sales was SEK 21.85 million compared to SEK 10.41 million a year ago. Net loss was SEK 11.42 million compared to SEK 17.45 million a year ago.
Basic loss per share from continuing operations was SEK 0.47 compared to SEK 0.78 a year ago. Diluted loss per share from continuing operations was SEK 0.47 compared to SEK 0.78 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -12.36% | 14.08M | |
| -20.45% | 10.82B | |
| +43.17% | 3.25B | |
| -35.86% | 2.11B | |
| -17.21% | 2.08B | |
| -29.81% | 1.48B | |
| +17.56% | 1.02B | |
| -4.37% | 733M | |
| -37.00% | 391M | |
| -46.94% | 383M |
SENZAGEN AB 
